FDA Approved: LEVETIRACETAM — Supplemental Application (Aryeh Pharma corp)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam from Aryeh Pharma Corp under ANDA 091485.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizure Disorders

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)